Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Most Undervalued Small Cap Stocks to Buy Right Now

In this article, we will list the 5 Most Undervalued Small Cap Stocks to Buy Right Now. Please visit 7 Most Undervalued Small Cap Stocks to Buy Right Now if you would like to see the extended list and the methodology behind it.

5. Perella Weinberg Partners (NASDAQ:PWP)

Perella Weinberg Partners (NASDAQ:PWP) is one of the most undervalued small cap stocks to buy right now. Goldman Sachs lifted the price target on Perella Weinberg Partners (NASDAQ:PWP) to $19.50 from $17.50 on April 14, reiterating a Sell rating on the shares. The firm told investors in a research note that the earnings estimates and price targets for investment banks were modestly adjusted based on final Dealogic data, highlighting slight increases in M&A and debt capital markets activity, with equity capital markets unchanged.

The rating update came after Perella Weinberg Partners (NASDAQ:PWP) announced on April 13 that it entered into a definitive agreement for the acquisition of Gleacher Shacklock. Headquartered in London, Gleacher Shacklock is a premier independent advisory firm with a focus and long-standing presence in the UK advisory market.

Perella Weinberg Partners (NASDAQ:PWP) stated that the transaction is anticipated to close in H2 2026, subject to customary closing conditions and regulatory approval. It further stated that the United Kingdom holds the leading position as the largest advisory market in Europe, with a continual acceleration in the cross-border transaction volume between the UK, Europe, and North America. According to the company, the acquisition considerably expands Perella Weinberg Partners’s (NASDAQ:PWP) presence in this critical market.

Perella Weinberg Partners (NASDAQ:PWP) is an advisory firm involved in the provision of strategic and financial advisory services. The company services individual entrepreneurs, private and institutional investors, large public multinational corporations, mid-sized public and private companies, creditor committees, and government institutions.

4. Adecoagro S.A. (NYSE:AGRO)

Adecoagro S.A. (NYSE:AGRO) is one of the most undervalued small cap stocks to buy right now. Adecoagro S.A. (NYSE:AGRO) was downgraded to Neutral from Buy by Citi on April 15, with the firm raising the price target on the stock to $15 from $13. The firm attributed the price target increase to factors such as the higher urea prices and better ethanol prices compared to previous expectations in the near term because of higher energy prices, along with supply disruptions related to the conflict in the Middle East. However, Citi also stated that the stock has priced in a better scenario given the unattractive yields/multiples and after the recent stock performance, up 83% year-to-date.

In a separate development, Adecoagro S.A. (NYSE:AGRO) was upgraded to Buy from Neutral on March 30, with the firm lifting the price target on the stock to $16.20 from $8. The firm stated that the shares do not reflect the company’s Profertil acquisition and higher sugar, ethanol, and urea prices. It further told investors in a research note that although the stock is up 80% year-to-date after the 79% increase in urea prices due to Middle East supply disruptions, the market is still underestimating Adecoagro’s (NYSE:AGRO) EBITDA and cash flow upside from its fertilizers unit.

Adecoagro S.A. (NYSE:AGRO) provides agricultural and agro-industrial products and services, with the company’s operations divided into the following segments: Farming, Sugar, Ethanol and Energy, and Land Transformation.

3. Pediatrix Medical Group, Inc. (NYSE:MD)

Pediatrix Medical Group, Inc. (NYSE:MD) is one of the most undervalued small cap stocks to buy right now. On April 13, Truist lifted the price target on Pediatrix Medical Group, Inc. (NYSE:MD) to $23 from $21, reiterating a Hold rating on the shares.

The rating update came as part of a broader research note previewing fiscal Q1 results in Healthcare Services, or HC. The firm told investors in a research note that it is continuing to remain broadly bullish on the stocks in its HC Services coverage universe, tied to factors such as a more favorable/stable reimbursement backdrop, continued strong demand trends, and overarching secular tailwinds. It also sees the recent Final Medicare Advantage Rule as an “encouraging data point”.

The firm further stated that it continues to believe that the sector is well-positioned, given that it is domestic, scaled, and defensive, adding that the group is also a beneficiary of AI/automation/interconnectivity. In addition, strong free cash flow and attractive financial flexibility are supporting the ongoing growth, investment/M&A/shareholder friendly initiatives.

Pediatrix Medical Group, Inc. (NYSE:MD) provides physician services, including neonatal care, maternal fetal care, and other pediatric subspecialty care.

2. Globant S.A. (NYSE:GLOB)

Globant S.A. (NYSE:GLOB) is one of the most undervalued small cap stocks to buy right now. Globant S.A. (NYSE:GLOB) announced on April 13 its naming as an Autodesk Tandem Digital Twin Solution Provider, expanding its 15-year collaboration with Autodesk for the acceleration of digital twin implementation across airports, manufacturing facilities, smart buildings, and logistics environments across the globe.

The company further stated that as part of the designation, Globant S.A. (NYSE:GLOB) will deliver enterprise system integrations, implementation services, and operational data enablement, supporting the adoption of Autodesk Tandem’s cloud-based digital twin platform across complex environments. Management said that the work is driven by Globant’s (NYSE:GLOB) Digital Twins Practice, focused on enabling organizations to build the foundational layer for Physical AI by connecting real-world assets with intelligent operational systems.

The company also provided additional context, citing a MarketsandMarkets 2025 report and stating that the global digital twin market is estimated to grow from around $21.14 billion to $149.81 billion between 2025 and 2030. The partnership thus positions Globant S.A. (NYSE:GLOB) and Autodesk Tandem to address the expanding demand through the integration of design data with live operational systems, supporting real-time decision making.

Globant S.A. (NYSE:GLOB) provides information technology services, including application development, testing, infrastructure management, and application maintenance.

1. Kemper Corporation (NYSE:KMPR)

Kemper Corporation (NYSE:KMPR) is one of the most undervalued small cap stocks to buy right now. On April 8, UBS cut the price target on Kemper Corporation (NYSE:KMPR) to $48 from $56, maintaining a Buy rating on the shares. The rating update came as the firm adjusted price targets as part of a preview for the insurance group.

In its operating results for fiscal Q4 2025, Kemper Corporation (NYSE:KMPR) reported a net loss of $8.0 million, or $0.13 per share, for the quarter, compared to net income of $97.4 million, or $1.51 per diluted share, for the same quarter in the prior year period. Adjusted consolidated net operating income was $14.6 million, or $0.25 per share, for fiscal Q4 2025, compared to $115.1 million, or $1.78 per diluted share, for fiscal Q4 2024.

Kemper Corporation (NYSE:KMPR) stated that the specialty P&C operating results were pressured by bodily injury severity, and that actions are underway to improve profitability. C. Thomas Evans, Jr., Interim CEO, stated that the company is focused on taking deliberate actions addressing factors affecting its recent performance, adding that Kemper Corporation (NYSE:KMPR) is bolstering execution across pricing, claims, and expenses while simultaneously diversifying its portfolio geographically.

Kemper Corporation (NYSE:KMPR) is a holding company involved in the property and casualty insurance and life and health insurance businesses. The company’s operations are divided into the Specialty Property and Casualty Insurance and Life Insurance segments.

While we acknowledge the potential of KMPR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KMPR and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.